Last updated: February 5, 2025
Sponsor: Wright State University
Overall Status: Active - Recruiting
Phase
1
Condition
Aging
Human Growth Hormone (Hgh)
Treatment
No Insulin-Lie Growth Factor 1
Insulin-Like Growth Factor 1
Clinical Study ID
NCT03932162
06694
Ages > 21 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Male/Female
White skin (Fitzpatrick types I and II)
Age 21-30 or 65 and older
Able to comprehend procedures/risks
Exclusion
Exclusion Criteria:
Known photosensitivity
Currently on photosensitizing medications
Diabetes Mellitus
History of abnormal scarring
History of skin infections
Known allergy to lidocaine local anesthetic
Pregnancy or nursing
Other serious health issues
Study Design
Total Participants: 24
Treatment Group(s): 2
Primary Treatment: No Insulin-Lie Growth Factor 1
Phase: 1
Study Start date:
September 06, 2019
Estimated Completion Date:
December 31, 2025
Connect with a study center
Wright State Physicians
Fairborn, Ohio 45324
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.